Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,041 | -7,573 | -33,152 | -26,001 | -19,310 |
| Depreciation Amortization | 116 | 60 | 250 | 188 | 127 |
| Accounts payable and accrued liabilities | -185 | -423 | 509 | 483 | 243 |
| Other Working Capital | 717 | -539 | 1,387 | 8 | 2,451 |
| Other Operating Activity | 2,274 | 1,696 | 1,566 | 1,100 | 961 |
| Operating Cash Flow | $-15,119 | $-6,779 | $-29,440 | $-24,222 | $-15,528 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,499 | 91 | N/A | N/A | N/A |
| Common Stock Issued | 24 | 4 | 338 | 339 | 331 |
| Other Financing Activity | -47 | 0 | 36,272 | 21,343 | 21,343 |
| Financing Cash Flow | $1,476 | $95 | $36,610 | $21,682 | $21,674 |
| Exchange Rate Effect | -1 | -1 | -1 | -1 | 2 |
| Beginning Cash Position | 43,072 | 43,072 | 35,903 | 35,903 | 35,903 |
| End Cash Position | 29,428 | 36,387 | 43,072 | 33,362 | 42,051 |
| Net Cash Flow | $-13,644 | $-6,685 | $7,169 | $-2,541 | $6,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,119 | -6,779 | -29,440 | -24,222 | -15,528 |
| Free Cash Flow | -15,119 | -6,779 | -29,440 | -24,222 | -15,528 |